Evicenter
MarkdownMedical informationP&T meetings
Ifezuntirgene inilparvovec (AMT-130)

Huntington's disease

Manufacturer
uniQure
Launch
Not announced
Last updated
291 sources

Product information and disease descriptionProduct descriptionProduct information

American hospital formulary service (AHFS), or other drug classification

3 evidence topics · 4 sources

EU classification: advanced therapy investigational medicinal product, gene therapy
FieldQuoted record
Advanced Therapy IMP (ATIMP)“Yes”
Gene therapy medical product“Yes”
Committee on Advanced therapies (CAT) has issued a classification for this product“No”
AHFS and Anatomical Therapeutic Chemical classification

No evidence found.